This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. Its structure, featuring a pyrrolidine ring and a bromophenyl group, makes it a valuable intermediate in the creation of molecules targeting neurological disorders, including Parkinson’s disease and other conditions related to dopamine regulation. Additionally, it is explored in the development of selective enzyme inhibitors, which can play a role in treating metabolic and inflammatory diseases. Its hydrochloride form enhances solubility, making it suitable for use in various experimental and formulation studies.